Clinical Trials Directory

Trials / Unknown

UnknownNCT03491098

The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Muteea Mubark Salmen Bakuwiri · Academic / Other
Sex
All
Age
4 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Otitis media with effusion (OME) is defined as effusion in the middle ear without signs and symptoms of an acute infection. It is a leading cause of hearing impairment in children, and its early and proper management can avoid hearing and speech impairment, which can cause developmental delay in children.Although many conditions such as enlarged adenoids, cleft palate, Down syndrome, Kartagener syndrome, and nasopharyngeal neoplasm are related to the role of eustachian tube (ET) dysfunction in the pathogenesis of OME, allergic, immunologic, and infectious factors have also been claimed. Treatment of OME is still a controversial issue, as conventional treatment approaches fail to provide satisfactory and permanent relief of otologic symptoms.There is lack of proven effectiveness of the commonly given treatments, such as antibiotics, decongestants, and antihistamines, which are potentially harmful and have disadvantages. Few in those studies,investigated topical intranasal steroid for OME treatment,and in those studies, the duration of intranasal steroid application was short and there was no hearing evaluation.

Detailed description

The aim of this study is to assess the efficacy of nasal steroids in management of OME by comparing its results with that of oral steroids and that of nasal saline spray. Sixty patients (4-12) years aged children with OME over a period for two months will be included in this study. Informed written consent will obtained from the parents of patient studied after explanation of the research purpose. Patient diagnosed clinically to have OME with type B tympanogram and conductive hearing loss will be enrolled in our study. Exclusion criteria: 1. Patients previously managed by ventilation tube. 2. Those who had cleft palate. The patients were divided into three equal groups. In group 1, 20 patients will be received steroids spray, for. 2 months In group 2, 20 patients will be received steroids for 1 month In group 3, 20 patients will be receive hypertonic sea water solution Otoscopic examination, basic audiological evaluation including pure tone audiometry, and immittancemetry will be performed before treatment and repeated at 3 and 6 months after treatment. The evaluation was performed using ORBITR 922 VERSION2 . Examiners will be blinded to the type of treatment. Tympanometry results were distinguished into four grades as classified by El-Anwar et al12: type A, normal curve (pressure 50/\_99 H2O); type C1 (negative pressure \_100/\_199 mm H2O); type C2 (negative pressure \_200/\_394 mm H2O); type B (flat curve).2,3,11 The average hearing thresholds at 500 Hz and 1, 2, and 4 kHz were used in the statistical comparison. Follow-up clinical examinations were done once per week for 3 weeks, at the end of treatment. The efficacy of nasal steroid for management of OME was compared with that of oral steroid and that of nasal sinomarin spray as placebo.

Conditions

Interventions

TypeNameDescription
DRUGMometasone Furoate sprayMometasone Furoate spray one puff in each nostril daily for 8 weeks hypertonic sea water solution spray one puff in each nostril daily for (8) weeks.
DRUGprednisolone sodium phosphate 15mgthree times per day for 1 week then gradual withdrawal over 2 weeks
DRUGhypertonic sea water solution sprayone puff in each nostril daily for 8 weeks

Timeline

Start date
2018-05-15
Primary completion
2019-04-30
Completion
2020-03-01
First posted
2018-04-09
Last updated
2018-04-18

Source: ClinicalTrials.gov record NCT03491098. Inclusion in this directory is not an endorsement.